Age-related macular degeneration

PBM for non-exudative age-related macular degeneration Cochrane review

Henein C, Steel DH. Cochrane Database of Systematic Reviews. 2021.

Source

A Cochrane review found uncertainty about whether PBM slows progression of non-exudative AMD.

Evidence grade

low

Effect direction

unclear

Panel relevance

not-panel-replicable

Key findings

  • The review included two published RCTs with 90 participants and 106 eyes.
  • There was no evidence of a meaningful clinical difference in best-corrected visual acuity at 12 months.
  • The authors called for better-designed trials powered for effectiveness and safety.

Protocol details

WavelengthsNot reported nm
IrradianceNot reported mW/cm2
FluenceNot reported J/cm2
Session timeNot reported minutes
FrequencyOphthalmology-device specific
DurationOphthalmology-device specific
Treatment areaEyes/retina
Device typeSpecialized ophthalmic PBM systems

Caveats

  • Very low to low certainty evidence.
  • Consumer panel eye exposure should not be encouraged.